Trials / Completed
CompletedNCT05689840
Association Between Post-covid Infection Status and Perioperative Morbidity: A Ambispective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (actual)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
With the knowledge of currently transmitted omicron variant being less virulent, over 90 percent of the Chinese population is fully vaccinated, and the Chinese health workers have sufficient experience treating the illness. China 's epidemic prevention and control has entered a new stage to restore the normal functioning of society and basic medical services, On Dec, 7, China released a circular on further optimizing its COVID-19 response, announcing 10 new prevention and control measures.This has marked the watershed for sharply increased number of elective surgical patients diagnosed with COVID-19 during preoperativley, fully recovered or during recovery. Beijing faced a wave of omicron infection starting that would result in of a wide range of population infections. At which time there is limited evidence regarding the optimal timing of surgery following SARS-CoV-2 infection especially for omiron among Chinsese patients .This study intends to explore the relationship between the incidence of postoperative complications after elective surgery and COVID-19 infection in Peking Union Medical College Hospital, and provide data support for the policy formulation of elective surgical timing for patients after COVID-19 infection.
Conditions
- COVID-19
- Complication of Anesthesia
- Complication of Surgical Procedure
- Complication,Postoperative
- Sars-CoV-2 Infection
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Receiving inpatient surgical intervention | Receiving inpatient surgical intervention in Peking Union Medical College Hospital |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-03-31
- Completion
- 2024-01-09
- First posted
- 2023-01-19
- Last updated
- 2024-01-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05689840. Inclusion in this directory is not an endorsement.